Evidence map›Paper›PMID 38600122›Full record

ArticleCancer gene therapy2024

Correction: SPRTN is involved in hepatocellular carcinoma development through the ER stress response.

Anja Batel, Mirjana Polović, Mateo Glumac, Oliver Šuman, Stipislav Jadrijević, Bernarda Lozić, Marija Petrović, Bobana Samardžija, Nicholas J Bradshaw, Karlo Skube and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Anja Batel *Laboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Mirjana Polović *Laboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Mateo Glumac *Laboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Oliver ŠumanDepartment of Abdominal Surgery, Merkur Clinical Hospital, Zajčeva 19, 10000, Zagreb, Croatia.
Stipislav JadrijevićDepartment of Abdominal Surgery, Merkur Clinical Hospital, Zajčeva 19, 10000, Zagreb, Croatia.
Bernarda LozićLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Marija PetrovićLaboratory for Human Genetics, University Hospital Split, Spinčićeva 1, 21000, Split, Croatia.
Bobana SamardžijaFaculty of Biotechnology & Drug Development, University of Rijeka, Radmile Matejčić 2, 51000, Rijeka, Croatia.
Nicholas J BradshawFaculty of Biotechnology & Drug Development, University of Rijeka, Radmile Matejčić 2, 51000, Rijeka, Croatia.ORCID http://orcid.org/0000-0001-5581-8828
Karlo SkubeSelvita, Prilaz baruna Filipovića 29, 10000, Zagreb, Croatia.
Vinko PaladaDepartment of Physiology, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Mislav AcmanOmics solutions, trg 101. Brigade HV 1, 10000, Zagreb, Croatia.
Ivana Marinović TerzićLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia. ivana.marinovic.terzic@mefst.hr.ORCID http://orcid.org/0000-0003-1109-4682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38600122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.